Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02139397
Title Study of DFMO in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Giselle Sholler
Indications

neuroblastoma

Therapies

Eflornithine

Bortezomib

Age Groups: child
Covered Countries USA

Facility Status City State Zip Country Details
Arkansas Children's Hospital Little Rock Arkansas 72202 United States Details
Connecticut Children's Hospital Hartford Connecticut 06106 United States Details
Arnold Palmer Hospital for Children- MD Anderson Orlando Florida 32806 United States Details
Helen DeVos Children's Hospital Grand Rapids Michigan 49503 United States Details
Children's Mercy Hospitals and Clinics Kansas City Missouri 64108 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field